Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. The QoLaN study
Blood Pressure, 09/30/09
Hermans MP et al. – The study demonstrates that nebivolol in mild to moderate hypertension is associated with overall improvements in QoL, with a marked BP–lowering effect, in mono–therapy, add–on or switch, irrespective of the glucose tolerance status. It may be hypothesized that its dual mode of action explains its BP–lowering effect as well as the tolerability
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy , 11/16/09
Current options for the treatment of resistant hypertension
Expert Review of Cardiovascular Therapy , 11/13/09
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Article Search
Sponsor


See Latest Articles


